APACMed promotes ethical interactions between the medical technology industry and health care professionals to advance its mission. The purpose of APACMed’s Code of Ethical Conduct for Interactions with Health Care Professionals is to facilitate ethical interactions between its Corporate Members that develop, manufacture, sell, market, or distribute medical technologies in Asia Pacific and those individuals and entities that use, recommend, purchase, or prescribe medical technologies in Asia Pacific.
Members commit to adhere to this standard by adopting and abiding by the ethical principles outlined in this Code. This Code is subject to the laws of each country, province, or region, and other codes of conduct, applicable to a Member. If a provision in law or another code of conduct applicable to a Member is more restrictive than the corresponding provision in this Code, the Member shall adhere to the more restrictive provision in the law or other code of conduct. Likewise, if a provision in this Code is more restrictive than the corresponding provision in law or another code of conduct applicable to a Member, the Member shall adhere to the more restrictive provision in this Code.
APACMed recognizes that collaborative interactions between Members and HCPs are essential to advancing medical technology and ensuring the safe and effective use of Members’ products and services.
APACMed is committed to ensuring that these interactions meet the highest ethical standards, preserve HCPs’ independent decision-making, and reinforce public confidence in the integrity of patient care, treatment, and product and service selection.
All interactions with HCPs must be:
(a) conducted in compliance with applicable laws and codes of conduct;
(b) based on the best interests of the patient; and
(c) appropriately documented.
In promoting or advertising their products and services to HCPs, Members must ensure that they comply with applicable laws and codes of conduct. All statements must be true, accurate, and substantiated.
In early 2016, the APACMed Board directed the Legal/ Ethics & Compliance Committee to review whether members should continue to be permitted to provide direct sponsorship funding to HCPs to enable them to attend third party educational events (in those jurisdictions in Asia Pacific where direct sponsorship continues to be permitted) and to provide recommendations to the Board. Following that review, in September 2016 the APACMed Board determined that, as of as of January 2018, members’ direct sponsorship of healthcare professionals to third party educational events would no longer be permitted. Revisions were made to the Code to reflect that decision, and the revisions were approved by the Board in February 2017.